2024 Asia‑Pacific survey of 204 Thermage users finds ideal candidates in their 40s, rising confidence, common same‑day combos with injectables, and practical tips on tips, settings and safety
InA 2024 cross‑sectional survey of 204 Thermage FLX-experienced physicians across eight Asia‑Pacific countries captures how real‑world practice has evolved. This January JDD article uncovered how: most clinicians view patients in their 40s with age‑related skin thinning as the best candidates, non‑responder rates have fallen since earlier reports, and combining the total FLX tip with injectables (often on the same day, typically starting with RF) has become routine.
Eye Thermage is widely used for noninvasive upper‑eyelid tightening and is commonly paired with periorbital injectables. Preferences vary regionally (eg, Korean doctors favor the 600 REP tip while many others use the 900 REP tip), annual intervals are the norm, and topical EMLA remains the favored anesthetic though some centers use sedation or nitrous oxide. Reported complications are usually transient (erythema), edema, occasional vesicles) but include rarer sequelae such as post‑inflammatory pigment changes and, with periorbital use, eye‑related complaints, underscoring the value of conservative energy settings, especially on the neck and eyelids. High rates of physician self‑treatment and satisfaction suggest confidence in outcomes, yet the survey reinforces the need for patient counseling on gradual results and realistic expectations.
Read the full survey for granular practice insights, including tip selection, energy settings, peri‑procedure comfort strategies and complication management, to refine your Thermage FLX protocols and patient counseling.
J Drugs Dermatol. 2026;25(1). doi:10.36849/JDD.9424
Blog write-up assisted by AI
